Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | MMP13 | P45452 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.48 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.48 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.48 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.48 |
| ▸ | CMA1 | P23946 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27583382 | 0.84 | TAAR1 (0.62) | CMA1 | |
| Bromide SCHEMBL3939442 | 0.82 | TAAR1 (0.60) | CMA1 | |
| Hydrochloric Acid SCHEMBL1792281 | 0.82 | IDO1 (0.63) | CMA1 | |
| SCHEMBL12802274 | 0.81 | CYP1A2 (0.54) | CYP1A2CTBP2MEN1KMT2AALDH1A1 | |
| SCHEMBL6513030 | 0.79 | CTBP2 (0.57) | CYP1A2CTBP2MEN1KMT2AALDH1A1 | |
| SCHEMBL2036351 | 0.78 | BLM (0.55) | CYP1A2CTBP2MEN1KMT2AALDH1A1 | |
| SCHEMBL2036352 | 0.78 | BLM (0.55) | CYP1A2CTBP2MEN1KMT2AALDH1A1 | |
| SCHEMBL27925870 | 0.78 | GRM2 (0.58) | CYP1A2CTBP2MEN1KMT2AGRM2 | |
| SCHEMBL29499675 | 0.78 | BLM (0.55) | CYP1A2CTBP2MEN1KMT2AALDH1A1 | |
| SCHEMBL28246110 | 0.77 | GRM2 (0.57) | CYP1A2CTBP2MEN1KMT2AGRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2655382-B1 | ORGANOZINC COMPLEXES AND PROCESSES FOR MAKING AND USING THE SAME | UNIV MUENCHEN LUDWIG MAXIMILIANS (DE) | 2022-09-28 | — | — | EP | disclosed |
| US-9273070-B2 | Organozinc complexes and processes for making and using the same | KNOCHEL PAUL (DE) | 2016-03-01 | — | — | US | disclosed |
| US-20140031545-A1 | ORGANOZINC COMPLEXES AND PROCESSES FOR MAKING AND USING THE SAME | LUDWIG-MAXIMILIAN-UNIVERSITAT MUNCHEN (DE) | 2014-01-30 | — | — | US | disclosed |
| EP-2655382-A1 | ORGANOZINC COMPLEXES AND PROCESSES FOR MAKING AND USING THE SAME | Ludwig-Maximilians-Universität München (DE) | 2013-10-30 | — | — | EP | disclosed |
| WO-2012085168-A1 | ORGANOZINC COMPLEXES AND PROCESSES FOR MAKING AND USING THE SAME | LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) | 2012-06-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140031545-A1 | ORGANOZINC COMPLEXES AND PROCESSES FOR MAKING AND USING THE SAME | ODC1, AOC1, ADH1C | CYP1A2 1830/4885CTBP2 1861/4885MEN1 673/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.